Dermatomyositis: Prevalence, Clinical Spectrum, Diagnostic Approach, and Management Strategies.

Area of Science:

• Rheumatology
• Immunology
• Dermatology

Background:

• Dermatomyositis is a rare inflammatory myopathy characterized by distinct skin manifestations and varying muscle/systemic involvement.
• Clinical presentations are diverse, ranging from muscle-predominant to amyopathic forms, complicating diagnosis and disease course prediction.
• Myositis-specific autoantibodies aid in identifying clinical patterns, organ involvement, and prognosis, including risks for interstitial lung disease and malignancy.

Purpose of the Study:

• To provide a comprehensive review of dermatomyositis, integrating current evidence on its epidemiology, clinical presentation, diagnosis, systemic associations, and management.
• To highlight diagnostic complexities arising from heterogeneous phenotypes and the absence of universal serologic markers.
• To discuss current and emerging therapeutic strategies and future directions for personalized care.

Main Methods:

• Critical review of existing literature on dermatomyositis.
• Integration of data on epidemiology, clinical features, diagnostic criteria, and treatment modalities.
• Analysis of the role of immunologic testing and histopathology in diagnosis.

Main Results:

• Dermatomyositis presents a wide spectrum of clinical phenotypes, necessitating a multifaceted diagnostic strategy.
• Myositis-specific autoantibodies are valuable prognostic indicators, correlating with specific clinical patterns and systemic complications.
• Current management involves systemic glucocorticoids, immunosuppressants, and intravenous immunoglobulin, with ongoing research into personalized therapies.

Conclusions:

• A comprehensive diagnostic approach combining clinical evaluation, supportive tests, and histopathology is crucial for dermatomyositis.
• Understanding disease heterogeneity and immune pathways is key to developing personalized treatment strategies.
• Future research should focus on refining diagnostic tools and tailoring therapies for improved patient outcomes in dermatomyositis.